SIGDCELLESYKDOM
Behandling av anemi
Norsk
Behandling av anemi
/assets/ct/7e6416ec85/images/syn_placeholder_sqr.png

Sigdcellesykdom

Behandling av anemi

A phase 1b/2 study of the efficacy and safety of combination hydroxyurea and dose-escalated erythropoietin for treatment of anemia in sickle cell disease (ACHiEvE-SCD). (åpner nytt vindu)

Adeyemo TA, Kiriza N, Oluwole FT, Jelinek M, Jonassaint J, Oluwole O, Saber C, Philips BJ, Akinsanya OJD, Osunkalu VO, DeCastro LM, Novelli EM, Xu JZ

Kilde‎: Blood 2024;144(Suppl 1):178-9.

Arkiv‎: DOI

DOI‎: 10.1182/blood-2024-205261

https://ashpublications.org/blood/article/144/Supplement%201/178/530726/A-Phase-1b-2-Study-of-the-Efficacy-and-Safety-of (åpner nytt vindu)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (åpner nytt vindu)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Kilde‎: Acta Haematol 1995;94(3):128-34.

Arkiv‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (åpner nytt vindu)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (åpner nytt vindu)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Kilde‎: Haematologica 2006;91(8):1076-83.

Arkiv‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (åpner nytt vindu)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (åpner nytt vindu)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Kilde‎: J Obstet Gynaecol 2007;27(1):82-3.

Arkiv‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (åpner nytt vindu)